Imaging in Cancer Drug Development

Imaging remains an important tool in oncology drug discovery and development. This noninvasive technology delivers significant time and cost reduction when used systematically and skillfully. Cambridge Healthtech Institute’s Imaging in Cancer Drug Development is designed to bring together leading imaging experts from industry and academia, as well as scientists and clinicians who use their services to accelerate cancer research.

Preliminary Agenda

IMAGING ADVANCES AND END POINTS IN CANCER RESEARCH

Translational Imaging in Oncology

Daniel P. Bradley, Ph.D., Head, Biomedical Imaging at Takeda Boston, Takeda Pharmaceuticals International Co.

Non-Invasive and Simultaneous Measurement of Pharmacokinetics and pharmacodynamics in Preclinical Cancer Models

Werner Scheuer, Research Leader, Pharma Research and Early Development, Discovery Oncology, Roche Diagnostics GmbH

Normalizing Tumor Microvasculature And Microenvironment

Dai Fukumura, M.D., Ph.D., Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital & Harvard Medical School

Clinical Translation of Near-Infrared Fluorescence Imaging for Image-Guided Surgery

John V. Frangioni, M.D., Ph.D., Professor, Department of Medicine and Radiology, Harvard Medical School

THERANOSTICS APPLICATIONS 

Preclinical Development Of Peptide Radiotracers For Detecting Visceral Amyloid Associated With Multiple Myeloma

Jonathan Wall, Ph.D., Professor of Medicine, Human Immunology and Cancer Program; Director, Amyloid and Preclinical Molecular Imaging Laboratory, University of Tennessee Graduate School of Medicine

PARP1 Status Annotation in Cancers of the Oral Cavity

Thomas Reiner, Ph.D., Assistant Member, Memorial Sloan-Kettering Cancer Center; Assistant Attending Chemist, Radiochemistry & Imaging Sciences Service; Assistant Professor, Weill Cornell Medical College

Toward Solid Tumor Models Replicating Therapeutic Responses In Humans

Jan E. Schnitzer, M.D., Director, Professor of Cellular & Molecular Biology, PRISM, Proteogenomics Research Institute for Systems Medicine

For questions or suggestions about the meeting, please contact:
Marina Filshtinsky, M.D.
Senior Director, Conferences,
Cambridge Healthtech Institute
T: (+1) 973-525-4667
E: mfilshtinsky@healthtech.com

For sponsorship and exhibit sales information including sponsored podium presentations, contact:
Joseph Vacca
Associate Director, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5431
E: jvacca@healthtech.com